Author Submission Guidelines

Welcome to The Cancer News, an independent news platform delivering trusted oncology and hematology insights to clinicians, researchers, policymakers, patients, and families worldwide. Our author submission guidelines provide a clear framework for contributing high-quality articles that bridge scientific rigor with accessible, patient-centered communication. Whether you're reporting on a practice-changing clinical trial, analyzing emerging therapies, examining health policy shifts, offering expert commentary, or exploring global oncology, you'll find a dedicated submission template below tailored to your article type. Each template outlines the recommended structure, word count, tone, and section-by-section guidance to help your work reach a broad professional and lay audience effectively.

At a glance, The Cancer News accepts five article formats:

Clinical Trial Coverage (1,500–2,500 words) — In-depth reporting on trial design, findings, and clinical implications
Field Updates (1,500–2,000 words) — Overviews of emerging therapies and evolving treatment landscapes
Expert Commentary (1,000–1,500 words) — Focused interpretation of trials, therapies, or trends from leading voices
Global Oncology (1,500–2,000 words) — Global perspectives on disparities, innovations, and best practices

All submissions should balance scientific accuracy with plain-language explanations, include verified references, and feature author headshots and bios where applicable. Please review the relevant template carefully before submitting your draft.

Please send submissions to: [email protected]

Tips for authors contributing to The Cancer News:

Keep total article length 1,500–2,000 words.
Use plain-language explanations for patient-focused sections.
Use bullet points for takeaways and key highlights.
Ensure accurate references for all trial results, guidelines, and statements.
Maintain clarity and balance between scientific detail and readability.

Author Submission Templates:

Clinical Trial Coverage Article - Author Submission Template

Target word count: 1,500–2,500 words
Audience: Oncologists, hematologists, and patients/families
Tone: Professional, clear, and accessible; include patient-friendly explanations where indicated

Introduction / Context (150–250 words) Brief description of the cancer type and current treatment landscape; why this trial matters
Trial Overview (150–250 words) Trial name, phase, design, patient population, endpoints, sponsor, presentation/publication venue
Key Clinical Findings (400–600 words) Efficacy: response rates, OS, PFS; Safety: adverse events, toxicity; optional patient-friendly summary
Comparison with Prior Trials / Standard of Care (200–300 words) Contextualize results with historical controls or first-line regimens; include expert commentary
Clinical Implications / Practice Takeaways (150–250 words) Treatment sequencing, patient selection, emerging strategies; bullet points recommended
Patient Perspective / Plain-Language Summary (150–200 words) Explain trial meaning for patients/families, side effects, benefits, quality-of-life considerations
Expert Commentary (100–150 words) Author or other expert insights; optional video/audio snippet
Key Takeaways Box (optional, 50–100 words) 3–5 bullets summarizing the most important points
FAQs (3–5 questions, 100–150 words) Example: What is the trial drug? Who is eligible? Side effects? How does it compare to standard treatments? Are trials available?
References / Links Include journal articles, conference abstracts, and internal Binaytara articles
Images / Figures Upload files of any images or figures. Please use high-resolution images. Please include a headshot image of each author.

Field Update Article - Author Submission Template

Target word count: 1,500–2,000 words
Audience: Oncologists, hematologists, and patients/families
Tone: Professional, clear, accessible; include patient-friendly explanations where indicated
Fill each section with relevant content; bullet points are allowed for clarity

Introduction / Context (200–250 words) Overview of the cancer type or therapeutic area and why this update is relevant
Emerging Therapies & Novel Agents (400–500 words) Highlight new drugs, combinations, or mechanisms. Include patient-friendly explanations of how therapies work and potential benefits.
Clinical Practice Updates (300–400 words) Describe how emerging therapies affect treatment algorithms, guidelines, sequencing, patient selection, and monitoring. Optional plain-language summary for patient relevance.
Key Trial Highlights (300–400 words) Summarize recent studies driving change, including trial names, endpoints, outcomes, and context with prior standard-of-care studies.
Expert Insights / Commentary (150–200 words) Author’s analysis of clinical implications, controversies, and future directions. Optional quote, video, or visual snippet.
Patient Perspective / Plain-Language Summary (150–200 words) Explain key updates in easy-to-understand terms. Discuss potential benefits, side effects, and questions patients may ask their care team.
Key Takeaways / Summary Box (50–100 words) 3–5 concise bullets summarizing the most important practical insights and trends.
FAQs (3–5 questions, ~100–150 words total) Examples: What are the newest therapies for [cancer type]? How do updates change standard treatment? Who may benefit? What trials are available? How are side effects managed?
References / Links Include recent journal publications, conference abstracts, guideline updates, and internal Binaytara articles.

Expert Commentary Article - Author Submission Template

Target word count: 1,000–1,500 words
Audience: Oncologists, hematologists, and patients/families
Tone: Professional, clear, and accessible; include patient-friendly explanations where indicated

Introduction / Context (150–200 words) Why this topic, trial, or therapy matters now
Expert Analysis / Interpretation (400–600 words) Discuss trial implications, mechanisms, clinical significance, pros/cons, and uncertainties
Clinical Implications / Practice Takeaways (200–300 words) Recommendations for sequencing, patient selection, follow-up; bullet points optional
Patient Perspective / Plain-Language Summary (100–150 words) Explain in plain language how this expert opinion may affect patient care
Key Takeaways / Highlights Box (3–5 bullets, 50–100 words)
References / Links Journal articles, conference abstracts, and internal Binaytara articles

Global Oncology Article - Author Submission Template

Target word count: 1,500–2,000 words
Audience: Oncologists, hematologists, policymakers, global health professionals, and patients/families
Tone: Professional, clear, accessible; highlight global relevance
Topics: Health equity, global oncology, cancer healthcare disparities

Introduction / Global Context (200–250 words) Overview of global oncology issues (access, disparities, innovations) Why this topic matters across countries or regions
Regional / Country Highlights (400–500 words) Updates from specific regions or countries regarding cancer care, guidelines, or programs Include differences in access, infrastructure, and outcomes
Innovations & Global Best Practices (300–400 words) Describe new approaches, collaborations, or strategies improving global cancer care Include patient-centered examples and scalable solutions
Data, Evidence & Outcomes (300–400 words) Present global data or studies supporting interventions or programs Highlight disparities, gaps, and measurable outcomes
Expert Commentary / Insights (150–200 words) Input from global oncology leaders, clinicians, or researchers Optional quote or multimedia snippet
Patient / Population Perspective (150–200 words) How global initiatives affect patients and communities Consider quality-of-life, equity, and access issues
Key Takeaways / Summary Box (50–100 words) 3–5 concise bullets summarizing practical insights for global oncology stakeholders
FAQs (3–5 questions, ~100–150 words) Example: How can global disparities in cancer care be addressed? What are emerging treatment models? Which regions show most progress?
References / Links Include peer-reviewed studies, global reports, guidelines, and internal Binaytara resources

To submit an article to The Cancer News for consideration, please email us at:

[email protected]